Hugh A. Sampson, M.D. serves as Chief Scientific Officer and is a member of both the Executive Committee and the Company’s Scientific Advisory Board, responsible for leading global scientific efforts, overseeing DBV’s research team, researching potential new applications of investigational Viaskin® for the treatment of food allergies and autoimmune disorders, and supporting the Company’s clinical development teams. Dr. Sampson is also the Kurt Hirschhorn Professor of Pediatrics at the Icahn School of Medicine at Mount Sinai and Director Emeritus of the Jaffe Food Allergy Institute. He continues to direct his NIH-funded translational research activities and to see patients in clinical practice. Dr. Sampson is a member of the National Academy of Medicine, past chair of the Section on Allergy & Immunology of the American Academy of Pediatrics and the past-president of the American Academy of Allergy, Asthma and Immunology.
Dr. Sampson received his M.D. from the State University of New York at Buffalo School of Medicine and his allergy/immunology fellowship at Duke University.